World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024.

Google Scholar 

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.

Article  PubMed  Google Scholar 

Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, et al. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. Lancet Respir Med. 2024;12(6):484–98.

Article  PubMed  PubMed Central  Google Scholar 

Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10): e1002152.

Article  PubMed  PubMed Central  Google Scholar 

Behr MA, Edelstein PH, Ramakrishnan L. Rethinking the burden of latent tuberculosis to reprioritize research. Nat Microbiol. 2024;9(5):1157–8.

Article  CAS  PubMed  Google Scholar 

Cohen A, Mathiasen VD, Schön T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54(3):1900655.

Article  PubMed  Google Scholar 

Knight GM, McQuaid CF, Dodd PJ, Houben R. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect Dis. 2019;19(8):903–12.

Article  PubMed  PubMed Central  Google Scholar 

Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131–8.

Article  CAS  PubMed  Google Scholar 

Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9(7): e1001270.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS ONE. 2012;7(3): e34156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reichler MR, Khan A, Sterling TR, Zhao H, Chen B, Yuan Y, et al. Risk factors for tuberculosis and effect of preventive therapy among close contacts of persons with infectious tuberculosis. Clin Infect Dis. 2020;70(8):1562–72.

Article  PubMed  Google Scholar 

Martinez L, Cords O, Horsburgh CR, Andrews JR. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020;395(10228):973–84.

Article  PubMed  PubMed Central  Google Scholar 

Deuffic-Burban S, Atsou K, Viget N, Melliez H, Bouvet E, Yazdanpanah Y. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. Int J Tuberc Lung Dis. 2010;14(4):471–81.

CAS  PubMed  Google Scholar 

Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest. 2007;131(5):1424–34.

Article  PubMed  Google Scholar 

Jo Y, Gomes I, Flack J, Salazar-Austin N, Churchyard G, Chaisson RE, et al. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries. EClinicalMedicine. 2021;31: 100707.

Article  PubMed  PubMed Central  Google Scholar 

Kasaie P, Pennington J, Gupta A, Dowdy DW, Kendall EA. The Impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates. Clin Infect Dis. 2024;78(1):133–43.

Article  CAS  PubMed  Google Scholar 

Mandal S, Bhatia V, Sharma M, Mandal PP, Arinaminpathy N. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach. BMC Med. 2020;18(1):163.

Article  PubMed  PubMed Central  Google Scholar 

Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11(1):16–26.

CAS  PubMed  Google Scholar 

Ryckman T, Weiser J, Gombe M, Turner K, Soni P, Tarlton D, et al. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. Lancet Glob Health. 2023;11(8):e1205–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin H, Jo Y, Chaisson RE, Turner K, Churchyard G, Dowdy DW. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. J Int AIDS Soc. 2020;23(10): e25629.

Article  PubMed  PubMed Central  Google Scholar 

Uppal A, Rahman S, Campbell JR, Oxlade O, Menzies D. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: a systematic review and meta-analysis. PLoS Med. 2021;18(9): e1003712.

Article  PubMed  PubMed Central  Google Scholar 

Muñoz L, Stagg HR, Abubakar I. Diagnosis and management of latent tuberculosis infection. Cold Spring Harb Perspect Med. 2015;5(11):a017830.

Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192–204.

CAS  PubMed  Google Scholar 

Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, et al. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(2):250–64.

Article  CAS  PubMed  Google Scholar 

Lindestam Arlehamn CS, Sidney J, Henderson R, Greenbaum JA, James EA, Moutaftsi M, et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol. 2012;188(10):5020–31.

Article  CAS  Google Scholar 

Ortiz-Brizuela E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, Miedy M, Lan Z, et al. Assessing the diagnostic performance of new commercial interferon-γ release assays for mycobacterium tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis. 2023;76(11):1989–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142(1):63–75.

Article  CAS  PubMed  Google Scholar 

Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, et al. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis. EClinicalMedicine. 2023;56: 101815.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection (WHO/UCN/TB/2022.1). Geneva: World Health Organization; 2022.

Google Scholar 

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis. Tests for TB infection. Geneva: World Health Organization; 2022.

Google Scholar 

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention—tuberculosis preventive treatment. 2nd ed. Geneva: World Health Organization; 2024.

Book  Google Scholar 

Goscé L, Allel K, Hamada Y, Korobitsyn A, Ismail N, Bashir S, et al. Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: a modelling study. PLOS Glob Public Health. 2023;3(12): e0002573.

Article  PubMed  PubMed Central  Google Scholar 

Pathmanathan I, Ahmedov S, Pevzner E, Anyalechi G, Modi S, Kirking H, et al. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings. Int J Tuberc Lung Dis. 2018;22(6):596–605.

Article  CAS  PubMed  Google Scholar